Pentazocine
- Generic Name
- Pentazocine
- Drug Type
- Small Molecule
- Chemical Formula
- C19H27NO
- CAS Number
- 359-83-1
- Unique Ingredient Identifier
- RP4A60D26L
Overview
The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)
Background
The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)
Indication
For the relief of moderate to severe pain.
Associated Conditions
- Mild pain
- Severe Pain
- Moderate Pain
Clinical Trials
FDA Approved Products
pentazocine and naloxone
Manufacturer:Sun Pharmaceutical Industries, Inc.
Route:ORAL
Strength:50 mg in 1 1
Approved: 2018/07/31
NDC:63304-506
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath